Indefinite Delivery Contract 36C25023D0057

Award Date 4/27/23
Last Date to Order 4/26/25
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The $2.29 million single-award IDC, with a period of performance through January 2030, is for the supply of radiopharmaceuticals, including specialized medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine procedures, PET scans,...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the provision of radiopharmaceuticals. The IDC, valued at up to $2.6 million, has an ultimate completion date of March 4, 2029 and is not set-aside. As a subsidiary of Jubilant Life Sciences Limited, Jubilant Radiopharma specializes in manufacturing,...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit organization, to provide radiopharmaceuticals and related products and services to support diagnostic imaging and treatment procedures at VA medical facilities. The IDC has a potential value of $3,000,000 and runs through September 30, 2028. Jubilant Radiopharma, which is...
The U.S. Department of Veterans Affairs (VA) awarded Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, an Indefinite Delivery Contract (IDC) valued at up to $39.8 million to provide radiopharmaceuticals to VA medical facilities. Jubilant Radiopharma, a for-profit organization and self-certified small disadvantaged business, will supply diagnostic imaging agents, therapeutic radiopharmaceuticals, and nuclear medicine supplies, including products such as Ga-68...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the procurement of nuclear medicine radiopharmaceuticals. The single-award IDC has a total contract ceiling of $220,000 and a performance period running through March 31, 2030. Jubilant Radiopharma, a for-profit small disadvantaged business, will provide a range of specialized...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded Jubilant Draximage Inc., doing business as Jubilant Radiopharma, Division Radiopharmaceutique, an Indefinite Delivery Contract (IDC) valued up to $3.5 million for the provision of radioactive isotopes and related radiopharmaceutical products and services. This single-award IDC with the VA VISN 10 network has a period of performance through September 30, 2026. Under this IDC, Jubilant Radiopharma, a...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, to supply radiopharmaceutical products such as gallium-68 dotatate. Valued at a ceiling of $1.5 million, this IDC has a period of performance through March 2026 and was awarded to Jubilant Radiopharma under unrestricted competition, with no set-aside designation....
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract has a ceiling value of $220,000.00 and a period of performance through March 31, 2030. Under this IDC, Jubilant Radiopharma will provide radiopharmaceuticals and nuclear medicine products to support diagnostic and treatment capabilities for veterans at VA...
The federal contract IDV awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, is for the supply of radiopharmaceuticals. The $740,177.94 firm-fixed-price delivery order contract is part of a larger $39.8 million multiple-award Indefinite Delivery Contract (IDC) with the VA's Network Contracting Office 8, as well as additional IDVs with the VA and Defense Health...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award indefinite delivery requirements contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, to provide radiopharmaceuticals in support of patient care services. Three firm fixed price delivery orders were issued against the contract for a total value of $1.58M over a two year base period ending in April 2022. Delivery orders were...
  • 36C25023D0057
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

The Department of Veterans Affairs (VA) Veterans Health Administration awarded a single-award Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. The $1.5 million IDC, which has a period of performance through April 2025, enables the VA to efficiently procure a range of specialized radioactive isotopes, imaging agents, and related services to support diagnostic imaging and cancer treatment procedures performed at VA medical facilities across multiple Veterans Integrated Service Networks (VISNs).

The IDC was awarded without any set-aside designations, though Jubilant Radiopharma maintains its small disadvantaged business status. To date, the VA has issued two firm-fixed price delivery orders under the IDC, valued at $150,000 and $249,999.83, for the provision of nuclear medicine radiopharmaceuticals to VA medical centers within VISN 10, which covers facilities in Georgia and surrounding states. These contracts support the VA's ongoing efforts to provide critical diagnostic and therapeutic radiopharmaceuticals to veterans receiving care at VA healthcare facilities nationwide.

Generated 1/28/25, 12:04 PM